Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Rectum”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06057831
What this trial is testing

PET/MRI in Rectal Cancer

Who this might be right for
Rectal Cancer
AHS Cancer Control Alberta 40
Large-scale testing (Phase 3)Study completedNCT00068692
What this trial is testing

Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer

Who this might be right for
Rectal Mucinous AdenocarcinomaRectal Signet Ring Cell AdenocarcinomaRecurrent Rectal Carcinoma+8 more
National Cancer Institute (NCI) 225
Not applicableStudy completedNCT00914537
What this trial is testing

Anal Cancer Screening Study

Who this might be right for
Anal Cancer
National Cancer Institute (NCI) 363
Large-scale testing (Phase 3)Ended earlyNCT01279681
What this trial is testing

Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer

Who this might be right for
Cognitive/Functional EffectsColorectal CancerNeurotoxicity
Alliance for Clinical Trials in Oncology 32
Not applicableStudy completedNCT06359730
What this trial is testing

Incidence and Risk Factors of Low Anterior Resection Syndrome

Who this might be right for
Colorectal Cancer
Zagazig University 120
Testing effectiveness (Phase 2)Temporarily pausedNCT05591534
What this trial is testing

Endorectal Brachytherapy for Rectal Cancer

Who this might be right for
Locally Advanced Rectal Carcinoma
University Hospital, Bordeaux 31
Not applicableEnded earlyNCT00532987
What this trial is testing

Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer

Who this might be right for
Rectal CancerColon CancerAnal Cancer
Stanford University 22
Testing effectiveness (Phase 2)Study completedNCT01289821
What this trial is testing

First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With Regorafenib

Who this might be right for
Colorectal Neoplasms
Bayer 54
Not applicableUnknownNCT05985252
What this trial is testing

Virtual Ileostomy Versus Conventional Loop Ileostomy

Who this might be right for
Rectal Neoplasms
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 500
Not applicableStudy completedNCT01287637
What this trial is testing

Early Closure of Temporary Ileostomy

Who this might be right for
Rectal Cancer
Herlev Hospital 89
Not applicableStudy completedNCT01182116
What this trial is testing

Quality of Life in Patients That Undergo J Pouch or Side to End Coloanal Anastomosis for Rectal Cancer

Who this might be right for
Rectal Cancer
The Cleveland Clinic 46
Not applicableUnknownNCT01271192
What this trial is testing

Efficacy and Safety Study of Neoadjuvant in Treating Patients With Resectable Local Recurrent Rectal Cancer

Who this might be right for
Rectal Cancer
Sun Yat-sen University 360
Large-scale testing (Phase 3)Ended earlyNCT00254436
What this trial is testing

A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal Patients

Who this might be right for
Gastrointestinal CancerRectal Cancer
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05726864
What this trial is testing

ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal CancerKRAS G12D+11 more
Elicio Therapeutics 158
Not applicableUnknownNCT04917263
What this trial is testing

IMMUNOlogical Microenvironment in REctal Adenocarcinoma Treatment.

Who this might be right for
Rectal Cancer
University of Padova 544
Early research (Phase 1)Study completedNCT00959127
What this trial is testing

ARRY-438162 (MEK162) in Patients With Advanced Cancer

Who this might be right for
Advanced Solid TumorsAdvanced or Metastatic Biliary CancerMetastatic Colorectal Cancer
Array Biopharma, now a wholly owned subsidiary of Pfizer 93
Large-scale testing (Phase 3)Active Not RecruitingNCT04922853
What this trial is testing

Comparison of the Pathological Effect Between 2 and 4 Cycles Neoadjuvant CAPOX for Low/Intermediate Risk II/III Rectal Cancer

Who this might be right for
Rectal CancerNeoadjuvant Chemotherapy
West China Hospital 554
Large-scale testing (Phase 3)Study completedNCT00056459
What this trial is testing

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.

Who this might be right for
Colorectal NeoplasmsColonic NeoplasmsRectal Neoplasms
Novartis 1,168
Not applicableLooking for participantsNCT06536127
What this trial is testing

Prospective Monocentric Study Evaluating the Circulating NK Cells Phenotype and the ImmunoScore® in Patients With Non Metastatic Rectal Cancer

Who this might be right for
Rectal CancerNon Metastatic Cancer
Institut Sainte Catherine 100
Not applicableUnknownNCT06368661
What this trial is testing

Dietary Factors Associated to Colorectal Premalignant Lesions (COLOMAR-1)

Who this might be right for
Nutrition Related Neoplasm/Cancer
Fundación Vithas 30
Next Page